Document:

Unassociated Document

Exhibit 10.2

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into effective as of March 24, 2011 (“Effective Date”) by and between LiveDeal, Inc., a Nevada corporation (the “Company”) and Kevin Hall (“Executive”).

In consideration of the mutual promises, covenants and agreements herein contained, intending to be legally bound, the parties agree as follows:

1.           Employment.  The Company hereby agrees to employ Executive, and Executive hereby agrees to serve, subject to the provisions of the Agreement, as an employee of the Company in the position of Chief Executive Officer.  Executive will perform all services and acts reasonably necessary to fulfill the duties and responsibilities of his positions and will render such services on the terms set forth herein and will report to the Company’s Board of Directors (the “Board”).  In addition, Executive will have such other executive and managerial powers and duties with respect to the Company as may reasonably be assigned to him by the Board, to the extent consistent with his positions and status as set forth above.  Executive is obligated to devote his full time, attention and energies to perform the duties assigned hereunder and Executive agrees to perform such duties diligently, faithfully and to the best of his abilities.  Notwithstanding the foregoing, Company acknowledges and agrees that during the Term, Executive shall have the right to have a “financial interest” in or serve as a consultant, officer or director of any non-competing business, subject to advance Board approval; provided that Executive agrees that engaging in such outside activities shall not interfere with the performance of Executive’s full-time duties hereunder.  Executive acknowledges that any such outside activities that involve an entity other than the Company or its subsidiaries will involve an entity independent of the Company and any actions or decisions Executive takes or makes on behalf of such entity will not be imputed to the Company or its subsidiaries.

 

2.           Term.  This Agreement is for a two-year period (the “Term”) commencing on the Effective Date hereof and terminating on the second anniversary of the Effective Date, or upon the date of termination of employment pursuant to Section 6 of this Agreement; provided, however, that the Term may be extended as mutually agreed to by the parties.

 

3.           Compensation.

 

(a)          Salary.  Executive shall be paid a salary at the annual rate of $225,000 (the “Salary”).  The Salary will at all times be payable in accordance with the Company’s regular payroll practices and subject to all applicable withholdings, including taxes.

 

(b)         Performance Bonuses.  Executive will be entitled to receive an annual performance bonus in the event the Company reaches certain performance measures established by the Compensation Committee of the Board or the entire Board.  The performance milestones shall be weighted 75% financial and 25% personal.  Executive’s target bonus will be 50% of the Salary.   All bonuses payable will be subject to all applicable withholdings, including taxes.

 

(c)          Stock Option.  Executive is entitled to an option to purchase from the Company for cash all or any part of an aggregate of 12,813 shares of the Company’s common stock (the “Option”) at an exercise price equal to the closing price of the Company’s common stock on the date of grant (“Grant Date”).  The Option will be granted pursuant to the Company’s 2003 Stock Plan and the Company’s standard form of Non-Qualified Stock Option Agreement.  The Option granted under this Agreement is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.  So long as Executive continues to be employed by the Company in accordance with this Agreement, the Option will vest and be exercisable according to the following schedule: one quarter (25%) on the first anniversary of the Grant Date and the remainder shall vest 1/36 at the end of each month thereafter over the next 36 months so long as Executive continues to provide services to the Company.  Notwithstanding the foregoing, all unvested shares shall become immediately vested and exercisable in the event there has occurred (i) a Change of Control involving the Company and (ii) the successor to the Company or the Company’s business terminates Executive within 12 months of such Change of Control or within such 12-month time period reduces Executives compensation and benefits from what they were immediately prior to the Change of Control and/or such successor company fails to assume the obligations of the Company under and become a party to this Agreement.

 

 

 

 

 

As used in this Agreement, a “Change in Control” shall mean any of the following events:

 

(i)           the Company is a party to a merger or consolidation, or series of related transactions, with a person other than an affiliate; or

 

(ii)          all or substantially all of the assets of the Company are, in any transaction or series of transactions, sold or otherwise disposed of (or consummation of any transaction, or series of related transactions, having similar effect), other than to an affiliate; or

 

(iii)         at least 51% of the Company’s outstanding shares are tendered to an unaffiliated third party

 

provided, however, that in no event shall a “Change in Control” be deemed to have occurred for purposes of this Agreement solely because the Company engages in an internal reorganization, which may include a transfer of assets to, or a merger or consolidation with, one or more affiliates.

 

4.           Business Expenses.  During the Term, the Company will reimburse Executive for all reasonable business expenses incurred by him in connection with his employment and the performance of his duties as provided hereunder, upon submission by the Executive of receipts and other documentation in conformance with the Company’s normal procedures for executives of Executive’s position and status.

 

5.           Benefits.  During the Term, Executive will be eligible to participate fully in all health and benefit plans available to senior officers of the Company generally, as the same may be amended from time to time by the Board.  Executive shall be entitled to four weeks of annual vacation in accordance with the Company’s standard vacation policy for executives.

 

6.           Termination of Employment.

 

(a)         Notwithstanding any provision of this Agreement to the contrary, the employment of Executive hereunder is at-will and will terminate on the first to occur of the following dates:

 

(i)           the date of Executive’s death;

 

(ii)          the date on which Executive has experienced a Disability (as defined below), and the Company gives Executive notice of termination on account of Disability;

 

(iii)         the date on which Executive has engaged in conduct that constitutes Cause (as defined below), and the Company gives notice of termination for Cause;

 

(iv)         the date on which Executive voluntarily terminates his relationship with the Company; or

 

 

2

 

 

(v)          the date on which the Company gives Executive notice of termination for any reason other than the reasons set forth in Sections 6(a)(i) through (iv) above.

 

(b)           For purposes of this Agreement, “Disability” will mean an illness, injury or other incapacitating condition as a result of which Executive is unable to perform, with reasonable accommodation, the services required to be performed under this Agreement for 30 consecutive days during the Term.  Executive agrees to submit to such medical examinations as may be necessary to determine whether a Disability exists, pursuant to such reasonable requests made by the Company from time to time.  Any determination as to the existence of a Disability will be made by a physician mutually selected by the Company and Executive.

 

(c)           For purposes of this Agreement, “Cause” will mean the occurrence of any of the following events, as reasonably determined by the Board:

 

(i)           Executive’s willful and continued refusal to substantially perform his duties hereunder, which the Company has given the Executive notice of in writing and which the Executive has not cured within 30 days of the receipt of such notice;

 

(ii)          Executive’s conviction of a felony, or his guilty plea to or entry of a nolo contendere plea to a felony charge; or

 

(iii)         Executive’s breach of any material term of this Agreement or the Company’s written policies and procedures, as in effect from time to time; provided, however, that with respect to Sections 6(c)(i) or (iii) above, such termination for Cause will only be effective if the conduct constituting Cause is not cured by Executive within 5 days of receipt by Executive of written notice specifying in reasonable detail the nature of the alleged breach.

 

(d)           Following termination of Executive’s employment with the Company for any reason, Executive shall fully cooperate with the Company in all matters relating to the winding up of Employee’s pending work including, but not limited to, any litigation in which the Company is involved, and the orderly transfer of any such pending work to such other employees as may be designated by the Company.

 

7.           Compensation in Event of Termination.  Upon termination of this Agreement and Executive’s employment, the Company will have no further obligation to Executive except to pay the amounts set forth in this Section 7.

 

(a)          In the event Executive’s employment is terminated pursuant to Section 6(a)(i), (ii), (iii) or (iv), Executive will be entitled to payment of any earned but unpaid Salary through the date of termination.  Any earned but unpaid bonuses, fees or payments due to Executive hereunder shall be paid to Executive as set forth herein.

 

(b)          In the event Executive’s employment is terminated pursuant to Section 6(a)(v), and provided that Executive (i) if a member of the Board, formally resigns in writing from the Board and as an officer and director of any subsidiary of the Company, and (ii) executes a valid release of any and all claims that Executive may have relating to his employment against the Company and its agents, including, but not limited to, its officers, directors and employees, in a form provided by the Company and that contains a 12-month non-solicitation clause and a non-competition clause with a restrictive period equal to the Severance Period (as defined below), Executive will be entitled to a lump sum payment equal to Executive’s Salary for a period (“Severance Period”) of (i) three months if the termination occurs within the first 12 months of the Term and (ii) six months if the termination occurs after the first anniversary of the Effective Date but prior to the expiration of the Term, subject to all applicable withholdings and taxes.  Any earned but unpaid bonuses, fees or payments due to Executive hereunder shall be paid to Executive as set forth herein.

 

3

 

 

 

8.           Confidentiality.  Executive covenants and agrees that he will not at any time during or after the end of the Term, without written consent of the Company or as may be required by law or valid legal process, directly or indirectly, use for his own account, or disclose to any person, firm or corporation, other than authorized officers, directors, attorneys, accountants and employees of the Company or its subsidiaries, Confidential Information (as hereinafter defined) of the Company.  As used herein, “Confidential Information” of the Company means information about the Company of any kind, nature or description, including but not limited to, any proprietary information, trade secrets, data, formulae, supplier, client and customer lists or requirements, price lists or pricing structures, marketing and sales information, business plans or dealings and financial information and plans as well as papers, resumes and records (including computer records) that are disclosed to or otherwise known to Executive as a direct or indirect consequence of Executive’s employment with the Company or service as a member of the Board, which information is not generally known to the public or in the businesses in which the Company is engaged.  Confidential Information also includes any information furnished to the Company by a third party with restrictions on its use or further disclosure.

 

9.           Inventions Assignment.  Executive hereby sells, transfers and assigns to the Company or to any person, or entity designated by the Company, all of the entire right, title and interest of the Executive in and to all inventions, ideas, disclosures and improvements, whether patented or unpatented, and copyrightable material, made or conceived by the Executive, solely or jointly, or in whole or in part, during or before the term hereof, which (i) relate to methods, apparatus, designs, products, processes or devices sold, leased, used or under construction or development by the Company, or (ii) otherwise relate to or pertain to the business, functions or operations of the Company.  Executive shall communicate promptly and disclose to the Company, in such form as the Company requests, all information, details and data pertaining to the aforementioned inventions, ideas, disclosures and improvements; and, whether during the term hereof or thereafter, the Executive shall execute and deliver to the Company such formal transfers and assignments and such other papers and documents as may be required of the Executive to permit the Company or any person or entity designated by the Company to file and prosecute the patent applications and, as to copyrightable material, to obtain copyright thereon. Any invention by the Executive within one year following the termination of this Agreement shall be deemed to fall within the provisions of this paragraph unless proved by the Executive to have been first conceived and made following such termination.

 

10.         Dispute Resolution.  Except for an action exclusively seeking injunctive relief, any disagreement, claim or controversy arising under or in connection with this Agreement, including Executive’s employment or termination of employment with the Company will be resolved exclusively by arbitration before a single arbitrator in accordance with the National Rules for the Resolution of Employment Disputes of the American Arbitration Association (the “Rules”), provided that, the arbitrator will allow for discovery sufficient to adequately arbitrate any claims, including access to essential documents and witnesses; provided further, that the Rules will be modified by the arbitrator to the extent necessary to be consistent with applicable law.  The arbitration will take place in Las Vegas, Nevada.  The award of the arbitrator with respect to such disagreement, claim or controversy will be in writing with sufficient explanation to allow for such meaningful judicial review as permitted by law, and that such decision will be enforceable in any court of competent jurisdiction and will be binding on the parties hereto.  The remedies available in arbitration will be identical to those allowed at law.  The arbitrator will be entitled to award reasonable attorneys’ fees to the prevailing party in any arbitration or judicial action under this Agreement, consistent with applicable law.  The Company and Executive each will pay its or his own attorneys’ fees and costs in any such arbitration, provided that, the Company will pay for any costs, including the arbitrator’s fee, that Executive would not have otherwise incurred if the dispute were adjudicated in a court of law, rather than through arbitration.

 

 

4

 

 

11.         Binding Agreement.

 

(a)         This Agreement is a personal contract and the rights and interests of Executive hereunder may not be sold, transferred, assigned, pledged, encumbered or hypothecated by him, provided that all rights of the Executive hereunder shall inure to the benefit of, and be enforceable by Executive’s personal or legal representatives, executors, heirs, administrators, successors, distributors, devisees and legatees.

 

(b)         In addition to any obligations imposed by law, any successor to Company (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the assets of the Company, is bound by this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.

 

12.         Disclosure Obligations.  During the Term, Executive agrees to make prompt and full disclosure to the Company of any change of facts or circumstances that may affect Executive’s obligations undertaken and acknowledged herein, and Executive agrees that the Company has the right to notify any third party of the existence and content of Executive’s obligations hereunder

 

13.         Return of Company Property.  Executive agrees that following the termination of his employment or service as a member of the Board for any reason, he will promptly return all property of the Company, its subsidiaries, affiliates and any divisions thereof he may have managed that is then in or thereafter comes into his possession, including, but not limited to, documents, contracts, agreements, plans, photographs, books, notes, electronically stored data and all copies of the foregoing, as well as any materials or equipment supplied by the Company to Executive.

 

14.         Entire Agreement.  This Agreement contains all the understandings between the parties hereto pertaining to the matters referred to herein, and supersedes all undertakings and agreements, whether oral or written, previously entered into by them with respect thereto.  Executive represents that, in executing this Agreement, he does not rely, and has not relied, on any representation or statement not set forth herein made by the Company with regard to the subject matter, bases or effect of this Agreement otherwise.

 

15.         Amendment or Modification, Waiver.  No provision of this Agreement may be amended or waived unless such amendment or waiver is agreed to in writing, signed by Executive and by a duly authorized officer of the Company.  The failure of either party to this Agreement to enforce any of its terms, provisions or covenants will not be construed as a waiver of the same or of the right of such party to enforce the same.  Waiver by either party hereto of any breach or default by the other party of any term or provision of this Agreement will not operate as a waiver of any other breach or default.

 

16.         Notices.  Any notice to be given hereunder will be in writing and will be deemed given when delivered personally, sent by courier or fax or registered or certified mail, postage prepaid, return receipt requested, addressed to the party concerned at the address indicated below or to such other address as such party may subsequently give notice of hereunder in writing:

 

 

5

 

 

To Executive at:

Kevin Hall

___________________

___________________

Phone: (___) ___-_____

To the Company at:

LiveDeal, Inc.

2490 E. Sunset Rd., #100

Las Vegas, NV 89120

Phone: (702) 939-0230

Fax: (702) 939-0246

Attention: CEO

With a copy (which shall not constitute notice hereunder) to:

Daniel M. Mahoney, Esq.

Snell & Wilmer L.L.P.

One Arizona Center

400 East Van Buren St.

Phoenix, Arizona 85004

Phone: (602) 382-6206

Fax: (602) 382-6070

Any notice delivered personally or by courier under this Section will be deemed given on the date delivered.  Any notice sent by fax or registered or certified mail, postage prepaid, return receipt requested, will be deemed given on the date faxed or mailed.  Each party may change the address to which notices are to be sent by giving notice of such change in conformity with the provisions of this Section.

17.         Severability.  In the event that any one or more of the provisions of this Agreement will be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remainder of the Agreement will not in any way be affected or impaired thereby.  Moreover, if any one or more of the provisions contained in this Agreement will be held to be excessively broad as to duration, activity or subject, such provisions will be constructed by limiting and reducing them so as to be enforceable to the maximum extent allowed by applicable law.

 

18.         Survivorship.  The respective rights and obligations of the parties hereunder will survive any termination of this Agreement to the extent necessary for the intended preservation of such rights and obligations.

 

19.         Each Party the Drafter.  This Agreement and the provisions contained in it will not be construed or interpreted for or against any party to this Agreement because that party drafted or caused that party’s legal representative to draft any of its provisions.

 

20.         Governing Law.  This Agreement will be governed by and construed in accordance with the laws of the State of Nevada, without regard to its conflicts of laws principles.

 

 

6

 

 

21.         Headings.  All descriptive headings of sections and paragraphs in this Agreement are intended solely for convenience, and no provision of this Agreement is to be construed by reference to the heading of any section or paragraph.

 

22.         Counterparts.  This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.

 

[Signature Page Follows]

 

 

 

 

 

 

 

 

 

7

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

	
LIVEDEAL, INC., a Nevada corporation

	 	
EXECUTIVE

	 
	  	 	  	 
	
/s/ Thomas Clarke

	 	
/s/ Kevin Hall

	 
	
By: Thomas Clarke

	 	
Kevin Hall

	 
	
Its: Chairman of the Compensation Committee

	  	 
	  	 	  	 
	
Dated: March 24, 2011

	 	
Dated: March 24, 2011

	 

  

8EXHIBIT 10.2

LICENSE AGREEMENT

THIS LICENSE AGREEMENT (“Agreement”) is made by InterComponentWare, AG (“ICW”) and CareAdvantage, Inc. (“CareAdvantage”) as of April 21, 2011;

WHEREAS, ICW and CareAdvantage have entered into a Memorandum of Understanding (“MOU”) as of April 15, 2011;

WHEREAS, one of the provisions of the MOU provides that in exchange for a payment of $175,000, CareAdvantage will grant ICW “a worldwide perpetual, royalty free license” to its Care Management Specifications (“Specifications”) and twelve (12) Care Management Plans to be selected by ICW;

WHEREAS, the parties desire to memorialize and clarify the provisions of the MOU relating to the aforesaid license;

NOW, THEREFOR, the parties agree as follows:

1.           License.

1.1           Grant of License to Care Management Specifications.  Subject to the terms and conditions of this Agreement, CareAdvantage hereby grants to ICW an exclusive, worldwide, irrevocable, perpetual, royalty-free, fully paid up, right and license under all CareAdvantage Intellectual Property Rights applicable to the Care Management Specifications owned or licensable by CareAdvantage.

1.2   Grant of License to Care Management Plans.  Subject to the terms and conditions of this Agreement, CareAdvantage grants ICW a non-exclusive, world-wide perpetual royalty-free license to use, copy, translate, distribute, publish, rent, lease, market, sublicense, pledge, assign, dispose of, encumber, transfer, alter, modify or enhance, create derivative works from or based on twelve (12) of the Care Management Plans selected in accordance with Section 1.3.

1.3           Selection of Care Management Plans.  ICW shall advise CareAdvantage in writing as to which twelve (12) of the 45 Care Management Plans (“Selected Care Management Plans”) described in Attachment A it elects to license pursuant to this Agreement.

1.4           Definitions.  The Care Management Specifications plus the Selected Care Management Plans are referred to collectively as “Intellectual Property”; updates to Intellectual Property are referred to as “Updates”; and Intellectual Property and Updates are referred to as the “Licensed Products.”

2.           Maintenance of Care Management Plans (“Maintenance”).   At ICW’s sole option, in exchange for  payment of the Maintenance Fees as set forth in this Agreement, CareAdvantage will provide to ICW the annual reviews and applicable updates to any or all of the Selected Care Management Plans.

  

 

  

3.           Ownership.

3.1 Generally.  All rights to and in the Licensed Products, including, but not limited to, copyrights and trade secret rights, shall remain the sole property of CareAdvantage, which holds title to each copy of the Licensed Products. Nothing provided herein (a) shall limit CareAdvantage’s rights to grant to any person or entity a license to use a copy of the Licensed Products, or (b) subject to the rights granted herein to ICW, shall limit CareAdvantage’s rights to sell or to otherwise dispose of the Licensed Products to any person or entity.

3.2 Warranty re Ownership.  CareAdvantage warrants that it is the owner of the Licensed Property and that it has the full power, authority and right to license the Licensed Property in the manner set forth in this License Agreement. In the event any third-party claims that the Licensed Property infringes on any patent, copyright, trademark or trade secret, CareAdvantage will, at its option, defend ICW against such claim, obtain the right to use such patent, copyright, trademark or trade secret, or refund any monies paid under this Agreement by ICW on account of the license to use the Licensed Property.

4.           No Other Warranties. EXCEPT AS PROVIDED IN SECTION 3.2, THE LICENSED PRODUCTS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND AND THERE ARE NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. No oral or written information or advice given by CareAdvantage, its agents, employees, affiliates, directors, or officers, shall create a warranty or in any way increase the scope of this warranty.

5.           Limitation of Liability. The liability of any or all of CareAdvantage and its affiliates or agents and any other person claiming through, on behalf of, or as harmed by ICW, is limited to a refund of any monies paid under this Agreement by ICW on account of the Licensed Property. Neither CareAdvantage nor its affiliates or agents shall be liable to ICW or to any other person for indirect, punitive, special, consequential or incidental damages (including, but not limited to, loss of profits or anticipated profits, loss by reason of shutdown in operation or increased expenses of operation, or other indirect loss or damage) of any nature arising from any cause whatsoever, even if CareAdvantage, its affiliates or agents have been advised of the possibility of such damages.

6.  Compensation.

a.           Generally. As consideration for the license granted by this Agreement, ICW shall pay CareAdvantage the sum of $175,000 as follows: (a) $125,000 upon execution of this License Agreement; and (b) the remaining $50,000 on or before May 14, 2011.

b.           Maintenance of Care Management Plans.  In order to receive updates and applicable reviews, ICW shall pay CareAdvantage the sum of $24,000 annually, for Updates to the Selected Care Management Plans.

7.           Miscellaneous

7.1           Notice. All notices and other communications hereunder shall be in writing and shall be deemed to have been given upon receipt, and shall be addressed as follows:

 

  

2

  

	
If to ICW:

	
InterComponentWare, AG

	  	
Altrottstrasse 31

	  	
69190 Walldorf

	  	
Germany

	  	
Attention:

	
Steffen Dietz, Center of Excellence

	
If to CareAdvantage:

	
CareAdvantage, Inc.

	  	
Metropolitan Corporate Center

	  	
485-A Route One South

	  	
Suite 200

	  	
Iselin, New Jersey 08830

	  	
Attention:

	
Dennis Mouras,

	  	  	
President & Chief Executive Officer

or to such other address as any party hereto shall have designated to the other party in accordance with the provisions of this Agreement.

7.2           Governing Law. This Agreement shall be construed in accordance with and governed by the laws of the State of New Jersey without giving effect to the principles of conflicts of laws.

7.3           Entire Agreement. Except as provided herein, this Agreement and its attachments constitutes the entire agreement between the parties with respect to the subject matter hereof This Agreement may not be released, discharged, or modified except by an instrument in writing signed by a duly authorized representative of each of the parties.

7.4           Binding Agreement; Assignability.  This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.

7.5           Severability.  If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid or unenforceable, such determination shall not affect the validity or enforceability of any other part or provision of this Agreement.

7.6           Disputes. I n the event of any dispute between the parties hereto arising out of or concerning this Agreement, the parties agree to use their reasonable best efforts to resolve any such dispute amicably, in good faith, and expeditiously prior to resorting to litigation.

7.7           Waiver.   No waiver by any party of any breach of any provision of this Agreement shall

constitute a waiver of any other breach of that or any other provision of this Agreement.

7.8           Parties in Interest.  This Agreement is made for the exclusive benefit of the parties hereto, their successors and assigns, and no person or entity other than CareAdvantage, ICW, their successors or assigns shall acquire or have any rights under or by virtue of this Agreement.

 

  

3

  

7.9           Counterparts.      This Agreement may be executed in several counterparts, each of which is an original but all of which shall constitute one and the same instrument.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date set forth above.

	
CAREADVANTAGE, INC.

	 	
INTERCOMPONENTWARE, AG

	  	 	  
	
Date: 5/10/2011

	 	
Date: 5/10/2011

	  	 	  
	
BY: 

	
s/Dennis Mouras

	 	
BY: 

	
s/Peter Kirschbauer

	
TITLE: PRESIDENT & CHIEF EXECUTIVE OFFICER

	 	
TITLE: Peter Kirschbauer, CEO

	  	 	  
	  	 	
BY:

	
s/Matthias Glück

	  	 	
TITLE: Matthias Glück, CFO

 

  

4

  

APPENDIX A

 

	
Care Management Plans

	
1

	
ALL

	
2

	
ALS

	
3

	
Asthma

	
4

	
BMT

	
5

	
Brain cancer

	
6

	
Breast Cancer

	
7

	
Burns

	
8

	
CAD

	
9

	
CHS

	
10

	
Chronic Renal Failure

	
11

	
CLL

	
12

	
Colorectal Cancer

	
13

	
CVA

	
14

	
Depression

	
15

	
DM Endocrine

	
16

	
DM Post Amputation

	
17

	
DM Integument

	
18

	
DYSPHAGIA

	
19

	
Generic Bowel Management

	
20

	
Generic Caretaking

	
21

	
Generic Cognition

	
22

	
Generic Community Resources

	
23

	
Generic Integument Pressure Ulcer

	
24

	
Generic Pain

	
25

	
Generic Pediatrics Growth Development

	
26

	
Generic Speech Language

	
27

	
Gestational Diabetes

	
28

	
Grief

	
29

	
GU Incontinence

	
30

	
Hepatitis C

	
31

	
High Risk OB Hypertension

	
32

	
High Risk OB Pre-Term Labor

	
33

	
HIV

	
34

	
HTN

	
35

	
Kidney Transplant

	
36

	
Lung Cancer

	
37

	
MS

	
38

	
Neuromuscular Impaired Mobility

	
39

	
Oncology Performance

	
40

	
Respiratory Dysfunction Asthma

	
41

	
Spinal Cord Injury

	
42

	
SCI Bowel Management

	
43

	
SCI Autonomic Dysreflexia

	
44

	
TBI

	
45

	
Weight Management

 

  

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}]]